Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$104M Sell
461,555
-7,061
-2% -$1.59M 0.1% 189
2023
Q4
$103M Sell
468,616
-7,632
-2% -$1.61M 0.1% 200
2023
Q3
$104M Sell
476,248
-33,394
-7% -$7.55M 0.11% 186
2023
Q2
$115M Sell
509,642
-36,264
-7% -$7.26M 0.11% 176
2023
Q1
$104M Buy
545,906
+6,843
+1% +$1.32M 0.11% 194
2022
Q4
$99.6M Sell
539,063
-8,349
-2% -$1.47M 0.11% 202
2022
Q3
$91M Sell
547,412
-28,816
-5% -$5.86M 0.1% 209
2022
Q2
$119M Sell
576,228
-22,286
-4% -$5.02M 0.12% 170
2022
Q1
$145M Buy
598,514
+10,719
+2% +$2.48M 0.12% 163
2021
Q4
$143M Buy
587,795
+37,245
+7% +$8.51M 0.08% 258
2021
Q3
$112M Buy
550,550
+18,539
+3% +$3.97M 0.06% 327
2021
Q2
$110M Buy
532,011
+420,059
+375% +$84.6M 0.06% 354
2021
Q1
$21.3M Sell
111,952
-1,821
-2% -$338K 0.01% 1124
2020
Q4
$21.6M Buy
113,773
+1,896
+2% +$354K 0.01% 1128
2020
Q3
$19.7M Sell
111,877
-7,567
-6% -$1.21M 0.01% 1036
2020
Q2
$18.3M Buy
119,444
+11,006
+10% +$1.68M 0.01% 988
2020
Q1
$15.2M Sell
108,438
-5,908
-5% -$884K 0.01% 969
2019
Q4
$17.4M Sell
114,346
-73,088
-39% -$10.7M 0.01% 1110
2019
Q3
$27.1M Buy
187,434
+90,519
+93% +$13.5M 0.02% 748
2019
Q2
$14.4M Buy
96,915
+15,436
+19% +$2.06M 0.01% 1099
2019
Q1
$10.4M Buy
81,479
+2,848
+4% +$335K 0.01% 1219
2018
Q4
$8.4M Buy
78,631
+7,771
+11% +$868K 0.01% 1256
2018
Q3
$8.11M Sell
70,860
-500
-0.7% -$56.5K 0.01% 1382
2018
Q2
$7.49M Sell
71,360
-2,328
-3% -$234K 0.01% 1432
2018
Q1
$6.88M Sell
73,688
-13,482
-15% -$1.23M 0.01% 1489
2017
Q4
$7.62M Buy
87,170
+12,930
+17% +$1.15M 0.01% 1461
2017
Q3
$6.56M Buy
74,240
+14,790
+25% +$1.25M 0.01% 1552
2017
Q2
$4.85M Sell
59,450
-15,287
-20% -$1.16M ﹤0.01% 1645
2017
Q1
$5.19M Sell
74,737
-7,001
-9% -$484K ﹤0.01% 1631
2016
Q4
$5.51M Sell
81,738
-11,460
-12% -$777K 0.01% 1580
2016
Q3
$6.81M Sell
93,198
-538,176
-85% -$38M 0.01% 1434
2016
Q2
$43.4M Buy
631,374
+451,699
+251% +$31.6M 0.05% 432
2016
Q1
$12.8M Sell
179,675
-249,974
-58% -$16.9M 0.02% 972
2015
Q4
$32.4M Buy
429,649
+337,550
+367% +$24.4M 0.04% 549
2015
Q3
$5.98M Buy
92,099
+13,873
+18% +$917K 0.01% 1431
2015
Q2
$5.04M Sell
78,226
-105,667
-57% -$7.13M ﹤0.01% 1726
2015
Q1
$12.9M Buy
183,893
+97,151
+112% +$6.41M 0.01% 1049
2014
Q4
$5.63M Sell
86,742
-25,590
-23% -$1.58M 0.01% 1681
2014
Q3
$6.06M Sell
112,332
-53,364
-32% -$2.9M ﹤0.01% 1613
2014
Q2
$8.86M Buy
165,696
+45,322
+38% +$2.33M 0.01% 1490
2014
Q1
$5.75M Sell
120,374
-21,667
-15% -$1.01M 0.01% 1655
2013
Q4
$6.83M Buy
142,041
+14,226
+11% +$650K 0.01% 1577
2013
Q3
$5.49M Sell
127,815
-30,508
-19% -$1.33M 0.01% 1555
2013
Q2
$6.79M Buy
+158,323
New +$6.81M 0.01% 1362

Other funds holding STE

Credit Suisse's STE Position: Q1 2024 in Review

Credit Suisse reduced its Steris (STE) stake by 1.5% in Q1 2024, selling an estimated $1.59M and leaving 461,555 shares worth $104M. The position accounts for 0.1% of the portfolio, ranked #189.

Credit Suisse first reported a position in STE in Q2 2013 and has held it in 44 quarters since. The position peaked at $145M in Q1 2022. 725 funds tracked by Wall St. Rank hold STE as of Q1 2024.

  • Credit Suisse held 461,555 shares of Steris worth $104M as of Q1 2024.
  • Credit Suisse sold 7,061 Steris shares in Q1 2024, an estimated $1.59M.
  • Steris made up 0.1% of Credit Suisse's portfolio in Q1 2024, its #189 holding.
  • Credit Suisse first reported a position in Steris in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Steris position peaked at $145M in Q1 2022.
  • 725 funds tracked by Wall St. Rank held Steris as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.